Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin
العنوان: | Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin |
---|---|
المؤلفون: | Lin Lin Lu, Ying Min Wu, Tao Liu, Huan Liang Liu, Wei Dong Wei, Xiangling Yang, Zhuo Jia Chen, Jun Du, Wei Ting Liang, Hao Liu, Hong-Sheng Wang |
المصدر: | Oncotarget |
بيانات النشر: | Impact Journals, LLC, 2015. |
سنة النشر: | 2015 |
مصطلحات موضوعية: | Lung Neoplasms, Time Factors, Triple Negative Breast Neoplasms, Vimentin, Metastasis, Cell Movement, Promoter Regions, Genetic, Triple-negative breast cancer, biology, EMT, Hep G2 Cells, Middle Aged, Gene Expression Regulation, Neoplastic, Receptors, Estrogen, Oncology, MCF-7 Cells, Female, RNA Interference, TNBC, Research Paper, Protein Binding, Signal Transduction, medicine.medical_specialty, Epithelial-Mesenchymal Transition, Drug Inverse Agonism, Mice, Nude, Antineoplastic Agents, Transfection, Breast cancer, fibronectin, Internal medicine, Nitriles, medicine, Animals, Humans, Epithelial–mesenchymal transition, Protein kinase B, PI3K/AKT/mTOR pathway, Retrospective Studies, Binding Sites, Dose-Response Relationship, Drug, ERRα, Cancer, medicine.disease, Xenograft Model Antitumor Assays, Fibronectins, Thiazoles, Endocrinology, biology.protein, Cancer research |
الوصف: | // Ying-Min Wu 1, * , Zhuo-Jia Chen 2, * , Hao Liu 3 , Wei-Dong Wei 2 , Lin-Lin Lu 1 , Xiang-Ling Yang 4, 5 , Wei-Ting Liang 2 , Tao Liu 2 , Huan-Liang Liu 4, 5 , Jun Du 1 , Hong-Sheng Wang 1 1 Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China 2 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China 3 Cancer Research Institute and Cancer Hospital, Guangzhou Medical University, Guangzhou 510095, China 4 Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology and The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China 5 Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou 510080, China * These authors have contributed equally to this work Correspondence to: Hong-Sheng Wang, e-mail: whongsh@mail.sysu.edu.cn , hongshengwang@foxmail.com Jun Du, e-mail: dujun@mail.sysu.edu.cn Keywords: ERRα, TNBC, EMT, fibronectin Received: April 15, 2015 Accepted: June 16, 2015 Published: June 26, 2015 ABSTRACT Triple-negative breast cancer (TNBC) patients have poor prognosis due to the aggressive metastatic behaviors. Our study reveals that expression of estrogen related receptor α (ERRα) is significantly ( p < 0.01) positively associated with high grade tumors and lymph node metastasis, while negatively correlated with overall survival (OS), in 138 TNBC patients. Targeted inhibition of ERRα by its inverse agonist XCT-790 or si-RNA obviously inhibits in vitro motility of TNBC cells. While over expression of ERRα triggers the invasion and migration of TNBC cells. Further, si-ERRα and XCT-790 inhibit the epithelial mesenchymal transition (EMT) of TNBC cells with increasing the expression of E-cadherin and decreasing fibronectin (FN) and vimentin. While XCT-790 has no effect on the expression of EMT related transcription factors such as Snail or Slug. Further, inhibitors of MAPK, PI3K/Akt, NF-κB signal molecules, which are activated by XCT-790, can not attenuate the suppression effects of XCT-790 on EMT. Alternatively, luciferase reporter gene assays and ChIP analysis indicate that ERRα can directly bind with FN promoter at ERR response element-3 (ERRE-1), ERRE-3, and ERRE-4, while XCT-790 reduces this bond. In vivo data show that ERRα expression is significantly ( p < 0.05) correlated with FN in clinical TNBC patients. In MDA-MB-231 tumor xenograft models, XCT-790 decreases the expression of FN, inhibits the growth and lung metastasis, and suppresses the EMT. Our results demonstrate that ERRα functions as a metastasis stimulator and its targeted inhibition may be a new therapeutic strategy for TNBC treatment. |
تدمد: | 1949-2553 |
DOI: | 10.18632/oncotarget.4436 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5015b7414d350f8d3b14078a6fcbfd8e https://doi.org/10.18632/oncotarget.4436 |
Rights: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....5015b7414d350f8d3b14078a6fcbfd8e |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....5015b7414d350f8d3b14078a6fcbfd8e 814 3 unknown 814.21728515625 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5015b7414d350f8d3b14078a6fcbfd8e&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5015b7414d350f8d3b14078a6fcbfd8e# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Lin+Lin+Lu%22">Lin Lin Lu</searchLink><br /><searchLink fieldCode="AR" term="%22Ying+Min+Wu%22">Ying Min Wu</searchLink><br /><searchLink fieldCode="AR" term="%22Tao+Liu%22">Tao Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Huan+Liang+Liu%22">Huan Liang Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Wei+Dong+Wei%22">Wei Dong Wei</searchLink><br /><searchLink fieldCode="AR" term="%22Xiangling+Yang%22">Xiangling Yang</searchLink><br /><searchLink fieldCode="AR" term="%22Zhuo+Jia+Chen%22">Zhuo Jia Chen</searchLink><br /><searchLink fieldCode="AR" term="%22Jun+Du%22">Jun Du</searchLink><br /><searchLink fieldCode="AR" term="%22Wei+Ting+Liang%22">Wei Ting Liang</searchLink><br /><searchLink fieldCode="AR" term="%22Hao+Liu%22">Hao Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Hong-Sheng+Wang%22">Hong-Sheng Wang</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Oncotarget ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Impact Journals, LLC, 2015. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2015 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Lung+Neoplasms%22">Lung Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Time+Factors%22">Time Factors</searchLink><br /><searchLink fieldCode="DE" term="%22Triple+Negative+Breast+Neoplasms%22">Triple Negative Breast Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Vimentin%22">Vimentin</searchLink><br /><searchLink fieldCode="DE" term="%22Metastasis%22">Metastasis</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+Movement%22">Cell Movement</searchLink><br /><searchLink fieldCode="DE" term="%22Promoter+Regions%2C+Genetic%22">Promoter Regions, Genetic</searchLink><br /><searchLink fieldCode="DE" term="%22Triple-negative+breast+cancer%22">Triple-negative breast cancer</searchLink><br /><searchLink fieldCode="DE" term="%22biology%22">biology</searchLink><br /><searchLink fieldCode="DE" term="%22EMT%22">EMT</searchLink><br /><searchLink fieldCode="DE" term="%22Hep+G2+Cells%22">Hep G2 Cells</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+Expression+Regulation%2C+Neoplastic%22">Gene Expression Regulation, Neoplastic</searchLink><br /><searchLink fieldCode="DE" term="%22Receptors%2C+Estrogen%22">Receptors, Estrogen</searchLink><br /><searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22MCF-7+Cells%22">MCF-7 Cells</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22RNA+Interference%22">RNA Interference</searchLink><br /><searchLink fieldCode="DE" term="%22TNBC%22">TNBC</searchLink><br /><searchLink fieldCode="DE" term="%22Research+Paper%22">Research Paper</searchLink><br /><searchLink fieldCode="DE" term="%22Protein+Binding%22">Protein Binding</searchLink><br /><searchLink fieldCode="DE" term="%22Signal+Transduction%22">Signal Transduction</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22Epithelial-Mesenchymal+Transition%22">Epithelial-Mesenchymal Transition</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Inverse+Agonism%22">Drug Inverse Agonism</searchLink><br /><searchLink fieldCode="DE" term="%22Mice%2C+Nude%22">Mice, Nude</searchLink><br /><searchLink fieldCode="DE" term="%22Antineoplastic+Agents%22">Antineoplastic Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Transfection%22">Transfection</searchLink><br /><searchLink fieldCode="DE" term="%22Breast+cancer%22">Breast cancer</searchLink><br /><searchLink fieldCode="DE" term="%22fibronectin%22">fibronectin</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Nitriles%22">Nitriles</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Animals%22">Animals</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Epithelial–mesenchymal+transition%22">Epithelial–mesenchymal transition</searchLink><br /><searchLink fieldCode="DE" term="%22Protein+kinase+B%22">Protein kinase B</searchLink><br /><searchLink fieldCode="DE" term="%22PI3K%2FAKT%2FmTOR+pathway%22">PI3K/AKT/mTOR pathway</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+Studies%22">Retrospective Studies</searchLink><br /><searchLink fieldCode="DE" term="%22Binding+Sites%22">Binding Sites</searchLink><br /><searchLink fieldCode="DE" term="%22Dose-Response+Relationship%2C+Drug%22">Dose-Response Relationship, Drug</searchLink><br /><searchLink fieldCode="DE" term="%22ERRα%22">ERRα</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer%22">Cancer</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Xenograft+Model+Antitumor+Assays%22">Xenograft Model Antitumor Assays</searchLink><br /><searchLink fieldCode="DE" term="%22Fibronectins%22">Fibronectins</searchLink><br /><searchLink fieldCode="DE" term="%22Thiazoles%22">Thiazoles</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%22">Endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22biology%2Eprotein%22">biology.protein</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+research%22">Cancer research</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => // Ying-Min Wu 1, * , Zhuo-Jia Chen 2, * , Hao Liu 3 , Wei-Dong Wei 2 , Lin-Lin Lu 1 , Xiang-Ling Yang 4, 5 , Wei-Ting Liang 2 , Tao Liu 2 , Huan-Liang Liu 4, 5 , Jun Du 1 , Hong-Sheng Wang 1 1 Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China 2 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China 3 Cancer Research Institute and Cancer Hospital, Guangzhou Medical University, Guangzhou 510095, China 4 Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology and The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China 5 Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou 510080, China * These authors have contributed equally to this work Correspondence to: Hong-Sheng Wang, e-mail: whongsh@mail.sysu.edu.cn , hongshengwang@foxmail.com Jun Du, e-mail: dujun@mail.sysu.edu.cn Keywords: ERRα, TNBC, EMT, fibronectin Received: April 15, 2015 Accepted: June 16, 2015 Published: June 26, 2015 ABSTRACT Triple-negative breast cancer (TNBC) patients have poor prognosis due to the aggressive metastatic behaviors. Our study reveals that expression of estrogen related receptor α (ERRα) is significantly ( p < 0.01) positively associated with high grade tumors and lymph node metastasis, while negatively correlated with overall survival (OS), in 138 TNBC patients. Targeted inhibition of ERRα by its inverse agonist XCT-790 or si-RNA obviously inhibits in vitro motility of TNBC cells. While over expression of ERRα triggers the invasion and migration of TNBC cells. Further, si-ERRα and XCT-790 inhibit the epithelial mesenchymal transition (EMT) of TNBC cells with increasing the expression of E-cadherin and decreasing fibronectin (FN) and vimentin. While XCT-790 has no effect on the expression of EMT related transcription factors such as Snail or Slug. Further, inhibitors of MAPK, PI3K/Akt, NF-κB signal molecules, which are activated by XCT-790, can not attenuate the suppression effects of XCT-790 on EMT. Alternatively, luciferase reporter gene assays and ChIP analysis indicate that ERRα can directly bind with FN promoter at ERR response element-3 (ERRE-1), ERRE-3, and ERRE-4, while XCT-790 reduces this bond. In vivo data show that ERRα expression is significantly ( p < 0.05) correlated with FN in clinical TNBC patients. In MDA-MB-231 tumor xenograft models, XCT-790 decreases the expression of FN, inhibits the growth and lung metastasis, and suppresses the EMT. Our results demonstrate that ERRα functions as a metastasis stimulator and its targeted inhibition may be a new therapeutic strategy for TNBC treatment. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1949-2553 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.18632/oncotarget.4436 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5015b7414d350f8d3b14078a6fcbfd8e" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5015b7414d350f8d3b14078a6fcbfd8e</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.18632/oncotarget.4436" linkWindow="_blank">https://doi.org/10.18632/oncotarget.4436</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....5015b7414d350f8d3b14078a6fcbfd8e ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.18632/oncotarget.4436
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 14
[StartPage] => 25588
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Lung Neoplasms
[Type] => general
)
[1] => Array
(
[SubjectFull] => Time Factors
[Type] => general
)
[2] => Array
(
[SubjectFull] => Triple Negative Breast Neoplasms
[Type] => general
)
[3] => Array
(
[SubjectFull] => Vimentin
[Type] => general
)
[4] => Array
(
[SubjectFull] => Metastasis
[Type] => general
)
[5] => Array
(
[SubjectFull] => Cell Movement
[Type] => general
)
[6] => Array
(
[SubjectFull] => Promoter Regions, Genetic
[Type] => general
)
[7] => Array
(
[SubjectFull] => Triple-negative breast cancer
[Type] => general
)
[8] => Array
(
[SubjectFull] => biology
[Type] => general
)
[9] => Array
(
[SubjectFull] => EMT
[Type] => general
)
[10] => Array
(
[SubjectFull] => Hep G2 Cells
[Type] => general
)
[11] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[12] => Array
(
[SubjectFull] => Gene Expression Regulation, Neoplastic
[Type] => general
)
[13] => Array
(
[SubjectFull] => Receptors, Estrogen
[Type] => general
)
[14] => Array
(
[SubjectFull] => Oncology
[Type] => general
)
[15] => Array
(
[SubjectFull] => MCF-7 Cells
[Type] => general
)
[16] => Array
(
[SubjectFull] => Female
[Type] => general
)
[17] => Array
(
[SubjectFull] => RNA Interference
[Type] => general
)
[18] => Array
(
[SubjectFull] => TNBC
[Type] => general
)
[19] => Array
(
[SubjectFull] => Research Paper
[Type] => general
)
[20] => Array
(
[SubjectFull] => Protein Binding
[Type] => general
)
[21] => Array
(
[SubjectFull] => Signal Transduction
[Type] => general
)
[22] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[23] => Array
(
[SubjectFull] => Epithelial-Mesenchymal Transition
[Type] => general
)
[24] => Array
(
[SubjectFull] => Drug Inverse Agonism
[Type] => general
)
[25] => Array
(
[SubjectFull] => Mice, Nude
[Type] => general
)
[26] => Array
(
[SubjectFull] => Antineoplastic Agents
[Type] => general
)
[27] => Array
(
[SubjectFull] => Transfection
[Type] => general
)
[28] => Array
(
[SubjectFull] => Breast cancer
[Type] => general
)
[29] => Array
(
[SubjectFull] => fibronectin
[Type] => general
)
[30] => Array
(
[SubjectFull] => Internal medicine
[Type] => general
)
[31] => Array
(
[SubjectFull] => Nitriles
[Type] => general
)
[32] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[33] => Array
(
[SubjectFull] => Animals
[Type] => general
)
[34] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[35] => Array
(
[SubjectFull] => Epithelial–mesenchymal transition
[Type] => general
)
[36] => Array
(
[SubjectFull] => Protein kinase B
[Type] => general
)
[37] => Array
(
[SubjectFull] => PI3K/AKT/mTOR pathway
[Type] => general
)
[38] => Array
(
[SubjectFull] => Retrospective Studies
[Type] => general
)
[39] => Array
(
[SubjectFull] => Binding Sites
[Type] => general
)
[40] => Array
(
[SubjectFull] => Dose-Response Relationship, Drug
[Type] => general
)
[41] => Array
(
[SubjectFull] => ERRα
[Type] => general
)
[42] => Array
(
[SubjectFull] => Cancer
[Type] => general
)
[43] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[44] => Array
(
[SubjectFull] => Xenograft Model Antitumor Assays
[Type] => general
)
[45] => Array
(
[SubjectFull] => Fibronectins
[Type] => general
)
[46] => Array
(
[SubjectFull] => Thiazoles
[Type] => general
)
[47] => Array
(
[SubjectFull] => Endocrinology
[Type] => general
)
[48] => Array
(
[SubjectFull] => biology.protein
[Type] => general
)
[49] => Array
(
[SubjectFull] => Cancer research
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lin Lin Lu
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ying Min Wu
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tao Liu
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Huan Liang Liu
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Wei Dong Wei
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Xiangling Yang
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Zhuo Jia Chen
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jun Du
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Wei Ting Liang
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hao Liu
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hong-Sheng Wang
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 26
[M] => 06
[Type] => published
[Y] => 2015
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 19492553
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 6
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Oncotarget
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |